Saori Watanabe Miyano
Overview
Explore the profile of Saori Watanabe Miyano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawano S, Kawada M, Fukushima S, Arai Y, Shibata T, Miyano S
Anticancer Res
. 2024 May;
44(6):2393-2406.
PMID: 38821585
Background/aim: Cholangiocarcinoma (CCA) is an aggressive tumor with limited treatment options especially in 2nd line or later treatments. Targeting fibroblast growth factor receptor (FGFR) 2 has recently emerged as a...
2.
Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, Ozawa Y, Yamaguchi S, et al.
Cancer Res
. 2021 Nov;
82(2):292-306.
PMID: 34753772
Combination therapies consisting of immune checkpoint inhibitors plus anti-VEGF therapy show enhanced antitumor activity and are approved treatments for patients with renal cell carcinoma (RCC). The immunosuppressive roles of VEGF...
3.
Ichikawa K, Miyano S, Minoshima Y, Matsui J, Funahashi Y
Sci Rep
. 2020 Feb;
10(1):2939.
PMID: 32076044
Anti-vascular endothelial growth factor (VEGF) therapy shows antitumor activity against various types of solid cancers. Several resistance mechanisms against anti-VEGF therapy have been elucidated; however, little is known about the...
4.
Hoshi T, Miyano S, Watanabe H, Sonobe R, Seki Y, Ohta E, et al.
Biochem Biophys Res Commun
. 2019 Apr;
513(1):1-7.
PMID: 30944079
Lenvatinib inhibits VEGF- and FGF-driven angiogenesis, and proliferation of tumor cells with activated FGF signaling pathways in preclinical models, and we previously demonstrated antitumor activity in human HCC xenograft tumor...
5.
Miyano S, Yamamoto Y, Kodama K, Miyajima Y, Mikamoto M, Nakagawa T, et al.
Mol Cancer Ther
. 2016 Aug;
15(11):2630-2639.
PMID: 27535969
The FGFR signaling pathway has a crucial role in proliferation, survival, and migration of cancer cells, tumor angiogenesis, and drug resistance. FGFR genetic abnormalities, such as gene fusion, mutation, and...